Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery
- PMID: 39138693
- DOI: 10.1208/s12249-024-02896-6
Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery
Abstract
Transdermal administration techniques have gained popularity due to their advantages over oral and parenteral methods. Noninvasive, self-administered delivery devices improve patient compliance and control drug release. Transdermal delivery devices struggle with the skin's barrier function. Molecules over 500 Dalton (Da) and ionized compounds don't permeate through the skin. Drug encapsulation in phospholipid-based vesicular systems is the most effective skin delivery technique. Vesicular carriers include bi-layered liposomes, ultra-deformable liposomes, ethanolic liposomes, transethosomes, and invasomes. These technologies enhance skin drug permeation by increasing formula solubilization, partitioning into the skin, and fluidizing the lipid barrier. Phospholipid-based delivery systems are safe and efficient, making them a promising pharmaceutical and cosmeceutical drug delivery technique. Still, making delivery systems requires knowledge about the physicochemical properties of the drug and carrier, manufacturing and process variables, skin delivery mechanisms, technological advances, constraints, and regulatory requirements. Consequently, this review covers recent research achievements addressing the mentioned concerns.
Keywords: elastic-liposome; ethanolic liposome; invasomes; phospholipid based vesicles; transdermal drug delivery; ultra-deformable vesicle.
© 2024. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Similar articles
-
Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.J Pharm Sci. 2017 Feb;106(2):423-445. doi: 10.1016/j.xphs.2016.10.001. Epub 2016 Nov 16. J Pharm Sci. 2017. PMID: 27865609 Review.
-
Transethosome: An ultra-deformable ethanolic vesicle for enhanced transdermal drug delivery.Chem Phys Lipids. 2023 Sep;255:105315. doi: 10.1016/j.chemphyslip.2023.105315. Epub 2023 Jun 24. Chem Phys Lipids. 2023. PMID: 37356610 Review.
-
Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties.Molecules. 2020 Jun 27;25(13):2959. doi: 10.3390/molecules25132959. Molecules. 2020. PMID: 32605117 Free PMC article. Review.
-
What's new in the field of phospholipid vesicular nanocarriers for skin drug delivery.Int J Pharm. 2020 Jun 15;583:119398. doi: 10.1016/j.ijpharm.2020.119398. Epub 2020 May 4. Int J Pharm. 2020. PMID: 32376441 Review.
-
A comprehensive review on transethosomes as a novel vesicular approach for drug delivery through transdermal route.J Liposome Res. 2024 Mar;34(1):203-218. doi: 10.1080/08982104.2023.2221354. Epub 2023 Jun 20. J Liposome Res. 2024. PMID: 37338000 Review.
References
-
- Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv Future Science. 2010;1:109–31. - DOI
-
- El-Sonbaty MM, Akl MA, Khalid M, Kassem AA. Does the technical methodology influence the quality attributes and the potential of skin permeation of Luliconazole loaded transethosomes? J Drug Deliv Sci Technol. Elsevier; 2022;103096.
-
- Akl MA, Ryad S, Ibrahim MF, Kassem AA. Formulation, and Optimization of Transdermal Atorvastatin Calcium-Loaded Ultra-flexible Vesicles; Ameliorates Poloxamer 407-caused Dyslipidemia. Int J Pharm. Elsevier; 2023;122917.
-
- Shah H, Nair AB, Shah J, Bharadia P, Al-Dhubiab BE. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats. DARU J Pharm Sci. 2019;27:59–70 (Springer). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources